Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients

International Journal of Cancer

Volumn 119, Issue 7, 2006, Pages 1732-1735

  Le Morvan, Valérie ^a   Longy, Michel ^a   Bonaïti Pellié, Catherine ^b   Bui, Binh ^a   Houédé, Nadine ^a   Coindre, Jean Michel ^a   Robert, Jacques ^a   Pourquier, Philippe ^a  

^a INSTITUT BERGONIÉ   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

Chromosomal aberrations; Nucleotide excision repair; Polymorphism; Sarcoma; Translocation

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; COCKAYNE SYNDROME; DERMATOFIBROSARCOMA PROTUBERANS; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOMA; SOFT TISSUE SARCOMA; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DNA; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; EXONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; SARCOMA; TRANSCRIPTION FACTORS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 33747463577     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22009     Document Type: Article

References (20)

1. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33.
2. Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 2000;462:149-58.
3. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 2002;11:1054-64.
4. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 2005;161:1-14.
5. Vogel U, Hedayati M, Dybdahl M, Grossman L, Nexo BA. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 2001;22:899-904.
6. Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B, Hemminki K. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002;23:599-603.
7. Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, Dusinska M, Kuricova M, Zamecnikova M, Musak L, Buchancova J, Norppa H, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004;25:757-63.
8. Kumar R, Hoglund L, Zhao C, Forsti A, Snellman E, Hemminki K. Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer 2003;103:671-5.
9. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC, 2002.
10. Hostein I, Menard A, Bui BN, Lussan C, Wafflart J, Delattre O, Peter M, Benhattar J, Guillou L, Coindre JM. Molecular detection of the synovial sarcoma translocation t(X;18) by real-time PCR in paraffin-embedded material. Diagn Mol Pathol 2002;11:16-21.
11. Park JY, Lee SY, Jeon HS, Park SH, Bae NC, Lee EB, Cha SI, Park JH, Kam S, Kim IS, Jung TH. Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 2002;36:15-16.
12. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002;62:1377-81.
13. Yu HP, Wang XL, Sun X, Su YH, Wang YJ, Lu B, Shi LY, Xiong CL, Li YY, Li F, Xu SQ. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2004;154:10-15.
14. Baccarelli A, Calista D, Minghetti P, Marinelli B, Albetti B, Tseng T, Hedayati M, Grossman L, Landi G, Struewing JP, Landi MT. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer 2004;90:497-502.
15. Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, Wang Q, Hayes S, Teitelbaum SL, Neugut AI, Santella RM. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:2053-8.
16. Jeon HS, Kim KM, Park SH, Lee SY, Choi JE, Lee GY, Kam S, Park RW, Kim IS, Kim CH, Jung TH, Park JY. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003;24:1677-81.
17. Tian M, Alt FW. Transcription-induced cleavage of immunoglobulin switch regions by nucleotide excision repair nucleases in vitro. J Biol Chem 2000;275:24163-72.
18. Sharpless NE, Ferguson DO, O'Hagan RC, Castrillon DH, Lee C, Farazi PA, Alson S, Fleming J, Morton CC, Frank K, Chin L, Alt FW et al. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell 2001;8:1187-96.
19. Szymanska J, Serra M, Skytting B, Larsson O, Virolainen M, Akerman M, Tarkkanen M, Huuhtanen R, Picci P, Bacchini P, Asko-Seljavaara S, Elomaa I et al. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 1998;23:213-19.
20. van Oosterom A, Maki R, Taron M, Sciot R, Fernandez Sousa-Faro JM, Tercero JC, Jimeno J, Rosell R. Impact of the DNA repair efficiency in the outcome of sarcoma patients treated with ET-743 (Yondelis). NCI-EORTC-AACR meeting, Geneva, 2004. Abstract No. 479.